CKD-371
/ Chong Kun Dang
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 22, 2023
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=32 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Not yet recruiting ➔ Completed
Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
September 16, 2022
CKD-371: Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=32 | Not yet recruiting | Sponsor: Chong Kun Dang Pharmaceutical
New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 2
Of
2
Go to page
1